Frequency of anti-infliximab antibodies: patients with RA in routine care – (May 2013) m1b1o

04/07/2013

Professor Robert Moots and Dr Steven Young (University of Birmingham School of Immunity and...

Professor Robert Moots and Dr Steven Young (University of Birmingham School of Immunity and Infection), discuss the therapeutic role of antibodies given directly to patients and their response to these antibodies. They review a paper by Krentil et al

Guidance on prescribing drugs in pregnancy and breastfeeding – May 2016 +1 año 05:02 Treating IgG4-related disease with rituximab +1 año 07:07 Dr Steven Zhao on comorbidities and disease activity in axSpA 2 días 07:54 Dr Gouri Koduri on patient perceptions of comorbidities +1 año 11:54 Dr Edward Roddy on the recently conducted gout audit +1 año 02:51 Ver más en APP Comentarios del episodio 6b6q10